ACTIVE

Eli Lilly Benelux

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
11,5 M €
+88.2% YoY
Revenue
294,3 M €
+106.2% YoY
Equity
20,4 M €
+2.3% YoY
Workforce
96,6 ETP
+11.2% YoY

What does Eli Lilly Benelux do?

Eli Lilly Benelux is a Public limited company incorporated in 1969. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles. It employs on average 96,6 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0406.754.454
Incorporation
19/06/1969
Legal form
Public limited company
Registered office
Rue du Marquis 1
1000 Bruxelles · BruxellesSee on map
Contributed capital
12 891 000,00 €
Latest accounts
31/12/2025
Average workforce
96,6 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods51460Air transport
Joint committees (1)
  • 200
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 6 financial years

202520242022202120202019
Income statement
Revenue294,3 M €142,7 M €111,1 M €121,5 M €135,7 M €102,9 M €
EBITDA15,7 M €7,9 M €6,5 M €9 M €7,5 M €15,4 M €
Operating result15,7 M €7,9 M €6,3 M €8,8 M €7,3 M €15,2 M €
Net result11,5 M €6,1 M €4,5 M €6,5 M €4,7 M €10,3 M €
Balance sheet
Equity20,4 M €19,9 M €19,9 M €19,9 M €19,9 M €30,2 M €
Total assets79,7 M €51,4 M €38,9 M €42,2 M €69,3 M €56,9 M €
Debts59,3 M €31,5 M €19 M €20,9 M €49,1 M €26,2 M €
Other
Workforce96,6 ETP86,9 ETP77,2 ETP83,0 ETP92,6 ETP95,2 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 2 ended

Active mandates

Frederic CLAIS

Director · since 29 juin 2020 · until 29 juin 2026

Active
Sandrine FERRIERE

Director · since 29 juin 2020 · until 29 juin 2026

Active

Ended mandates

Frédéric CLAIS

Director · since 28 juin 2019 · until 29 juin 2020

Ended
Sandrine FERRIERE

Director · since 28 juin 2019 · until 29 juin 2020

Ended
At this address

Other companies at this address

CompanyCBE no.
Agence Fédérale de Contrôle Nucléaire● Active
0254.487.220
ALLEGIS GLOBAL SOLUTIONS (Belgium)● Active
0627.963.944
ALLEGIS GROUP (Belgium)● Active
0543.691.037
ARCADIS BELGIUM● Active
0426.682.709
Arcadis-Fortum-KH Engineering● Active
1035.306.932
Becommerce● Active
0894.199.943
Belgian Mobile ID● Active
0541.659.084
ELI LILLY BELGIAN PENSION FUNDS● Active
0432.324.545
Euronext Brussels● Active
0242.100.122
Euronext Corporate Solutions Belgium● Active
0804.370.223
FESTIVAL VAN VLAANDEREN INTERNATIONAAL BRUSSEL - EUROPA● Active
0410.944.359
Fonds tot bevordering van het industrieel onderzoek in Vlaanderen● Active
0254.056.757
FORMA DESIGN STUDIO● Active
0552.919.202
maatschap Arcadis - SBE● Active
0716.636.790
PLAN EUROPE AISBL● Active
1020.295.092
Plan International Belgique● Active
0425.420.917
Preventieve Gezondheidszorg in Vlaanderen● Active
0457.702.220
S.M. Arcadis - Assar● Active
0663.763.179
TEKsystems Global Services (Belgium)● Active
0786.640.801
THV Arcadis - Grontmij● Active
0564.886.032
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/07/202629/07/202519/07/202427/07/202326/07/202220/07/2021
General meeting30/06/202630/06/202528/06/202430/06/202330/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202622/07/2026FrenchPDF
Full model31/12/202430/06/202529/07/2025FrenchPDF
Full model31/12/202328/06/202419/07/2024FrenchPDF
Full model31/12/202230/06/202327/07/2023FrenchPDF
Full model31/12/202130/06/202226/07/2022FrenchPDF
Full model31/12/202030/06/202120/07/2021FrenchPDF
Full model31/12/201929/06/202025/08/2020FrenchPDF
Full model31/12/201828/06/201908/07/2019FrenchPDF
Full model31/12/201729/06/201804/07/2018FrenchPDF
Full model31/12/201630/06/201720/07/2017FrenchPDF
Full model31/12/201530/06/201614/07/2016FrenchPDF
Full model31/12/201430/06/201530/07/2015FrenchPDF
Full model31/12/201330/06/201431/07/2014FrenchPDF
Full model31/12/201228/06/201323/08/2013FrenchPDF
Full model31/12/201129/06/201222/08/2012FrenchPDF
Full model31/12/201030/06/201126/07/2011FrenchPDF
Full model31/12/200930/06/201009/09/2010FrenchPDF
Full model31/12/200806/07/200922/07/2009FrenchPDF
Full model31/12/200721/11/200817/02/2009FrenchPDF
Full model31/12/200629/06/200715/02/2008FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 2 ended

Active mandates

Frederic CLAIS

Director · since 29 juin 2020 · until 29 juin 2026

Active
Sandrine FERRIERE

Director · since 29 juin 2020 · until 29 juin 2026

Active

Ended mandates

Frédéric CLAIS

Director · since 28 juin 2019 · until 29 juin 2020

Ended
Sandrine FERRIERE

Director · since 28 juin 2019 · until 29 juin 2020

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates15/09/2026
    Renouvellement du mandat des administrateurs
    PDF
  • Mandates18/09/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates01/07/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/09/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Other04/09/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates13/09/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/09/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/01/2020
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202511,5 M €↑
  2. 30/06/2025
    nominationEY Réviseurs d'Entreprises SRL — commissaire
  3. 30/06/2025
    nominationCarlo-Sébastien D'Addario — représentant permanent
  4. 2024
    Annual accounts 20246,1 M €↑
  5. 12/04/2024
    nominationTinne Glassée — Représentant
  6. 12/04/2024
    nominationSébastien Massart — Représentant
  7. 12/04/2024
    nominationJan Theuwis — Représentant
  8. 05/06/2023
    nominationTinne Glassée — Senior Director Medical Shared Services
  9. 2022
    Annual accounts 20224,5 M €↓
  10. 30/06/2022
    reconductionEY Réviseurs d'Entreprises — commissaire
  11. 2021
    Annual accounts 20216,5 M €↑
  12. 2020
    Annual accounts 20204,7 M €↓
  13. 2019
    Annual accounts 201910,3 M €
  14. 23/01/2019
    revocationBénédicte Van Maele — pouvoirs liés à la division “Medical Shared Services”
  15. 19/06/1969
    IncorporationPublic limited company